This week, a report for the Medicaid and CHIP Payment and Access Commission (MACPAC) examines the enrollment of likely eligible Medicare beneficiaries in Medicaid programs that assist with Medicare Part B premiums and cost-sharing, known as the Medicaid Savings Programs (MSPs). Using the most recently available data (2009 and 2010), the analysis shows that participation in the MSPs remains low.

The Centers for Medicare & Medicaid Services (CMS) recently announced that the average basic premium for a Part D prescription drug plan is estimated to be $33.50 per month in 2018. This projected average premium is a slight decrease from the average monthly premium in 2017 ($34.70) and represents the continued relative stability of Part D premiums. It is important to note that while the average, basic premium is lower in 2018, beneficiary premiums will vary—some increasing and some decreasing next year.

This week, the Kaiser Family Foundation (KFF) released a new issue brief examining a recent hot topic—areas with few or no insurers participating in Affordable Care Act (ACA) marketplaces. KFF compared these areas to places where there are very few or no Medicare Advantage (MA) plans offered this year to people with Medicare.

Nationwide, there are currently 19 counties—in Nevada, Indiana, and Ohio—that will have no ACA marketplace plans for sale in 2018. This number has been shrinking as insurers fill some of the gaps, so it is possible each of these counties will have coverage in 2018.

Last week, Medicare celebrated 52 years since it was signed into law. In those 52 years, Medicare has provided guaranteed health benefits to millions of older adults and people with disabilities. Today, 57 million Americans and their families rely on Medicare for basic health and economic security and the program remains on solid footing.

Early this morning, the U.S. Senate once again defended the American people and rejected a bill that would have devastated American families, led to tens of millions of people losing coverage, and put the Medicaid program at risk. The “Health Care Freedom Act,” the so-called “skinny repeal” bill, was defeated 49-51, ending this partisan attempt to repeal the Affordable Care Act (ACA) without a reasonable substitute that would protect the coverage and care for all Americans.

This week, the House Budget Committee approved a 2018 budget resolution that would end Medicare’s guarantee of health coverage by converting the program to a premium support system. It would cut Medicare spending by $487 billion, largely by shifting more health care costs to beneficiaries. This is in contrast to President Trump’s budget, which spares Medicare from cuts.

It’s been an eventful couple of weeks when it comes to Congress’s efforts to repeal the Affordable Care Act (ACA). Last week, it appeared the Senate would not be able to pass any bills, or even bring any bills to the floor for a vote. This week, the Senate voted on several health care bills and each one was defeated. Here’s what you need to know:

Today, Stacy Sanders, federal policy director of the Medicare Rights Center, testified in support of a proposed law that would increase the civil monetary penalties and criminal fines for certain types of Medicare fraud at a hearing held by the Subcommittee on Health of the U.S. House Committee on Energy and Commerce. The hearing focused on a number of bipartisan bills to improve Medicare, including the Medicare Civil and Criminal Penalties Update Act of 2017 (H.R. 3245).

In a shocking twist, Senate leadership decided this week that they will no longer advance the Better Care Reconciliation Act, a bill that would have slashed Medicaid, spiked costs for older adults, and yanked coverage away from 22 million Americans. This news would be welcome, if not for reports that the Senate is now rumored to turn to an already discredited scheme to repeal the Affordable Care Act (ACA) without a meaningful and simultaneous replacement.

The Trustees find that the Medicare Hospital Insurance (Part A) Trust Fund is solvent through 2029—a year longer than previously predicted—and that in 2016 the Trust Fund had a $5.4 billion surplus, with surpluses anticipated through 2022. Further, the Supplemental Medical Insurance (Part B and Part D) Trust Fund remains on firm financial footing, and last year’s warning that 2017 growth would trigger the creation of an Independent Payment Advisory Board (IPAB) did not come to fruition.